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a b s t r a c t
Expression of the multi-PDZ protein Pdzd2 (PDZ domain-containing protein 2) is enriched in pancreatic
islet  cells, but not in exocrine or  cells, suggesting a role for Pdzd2 in the regulation of pancre-
atic -cell function. To explore the in vivo function of Pdzd2, Pdzd2-deficient mice were generated.
Homozygous Pdzd2mutantmicewere viable and their grossmorphology appeared normal. Interestingly,
Pdzd2-deficient mice showed enhanced glucose tolerance in intraperitoneal glucose tolerance tests and
their plasma insulin levels indicated increased basal insulin secretion after fasting. Moreover, insulin
release from mutant pancreatic islets was found to be twofold higher than from normal islets. To verify
the functional defect in vitro, Pdzd2 was depleted in INS-1E cells using two siRNA duplexes. Pdzd2-
depleted INS-1E cells also displayed increased insulin secretion at low concentrations of glucose. Our
results provide the first evidence that Pdzd2 is required for normal regulation of basal insulin secretion.
© 2009 Published by Elsevier Ireland Ltd.
1. Introduction21
Insulin produced by pancreatic  cells is the key hormone22
responsible for maintaining glucose homeostasis. The regulation23
of insulin exocytosis in  cells is complicated and has a num-24
ber of mechanisms involved (MacDonald et al., 2005; Rorsman25
et al., 2000; Straub and Sharp, 2002). Upon the challenge of26
a stimulus, e.g. glucose, exocytosis of insulin is triggered. Such27
glucose-stimulated insulin secretion (GSIS) is commonly distin-28
guished as a biphasic process which depends on the rise of [Ca2+]i.29
As the extracellular glucose concentration increases above 6mM,30
glucose enters rodent  cells through Glut2 transporters (Thorens31
et al., 1988). Subsequent degradation of glucose causes an eleva-32
tion in the ATP/ADP ratio, and hence directs the closure of the33
KATP channel. Followed by membrane depolarization, the influx34
of Ca2+ activates the exocytosis of insulin granules (Ashcroft and35
Rorsman, 1989; Ammala et al., 1993). As defective or deficient36
insulin secretory responses that result from impaired pancreatic37
-cell functions lead to diabetesmellitus (Ashcroft, 2005; Koster et38
al., 2005), an understanding of the regulatory mechanisms of GSIS39
is definitely relevant to the pathogenesis and treatment of diabetes.40
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Pdzd2 [previously named KIAA0300 (Nagase et al., 1997), PIN- 41
1 (Thomas et al., 1999), PAPIN (Deguchi et al., 2000), activated in 42
prostate cancer (AIPC, Chaib et al., 2001)] is a multi-PDZ protein 43
expressed in multiple tissues including heart, brain, lung and pan- 44
creas (Yeung et al., 2003). Immunohistochemical analyses revealed 45
selective expression of Pdzd2 in pancreatic islet  cells, but not 46
in exocrine or glucagon-secreting  cells (Ma et al., 2006). Pdzd2 47
cDNAs were originally cloned based on the protein’s binding and 48
expression properties but its function remains obscure as no func- 49
tional analysis in animal or cell model has been reported. Pdzd2 50
contains six different PDZ protein–protein interaction domains, 51
which are thought to function by acting as molecular scaffolds 52
to facilitate the assembly of macromolecular complexes (Nourry 53
et al., 2003; Kim and Sheng, 2004; Harris and Lim, 2001). Pdzd2 54
shows the strongest sequence match to pro-interleukin-16 at the 55
carboxy-terminus (Yeung et al., 2003; Baier et al., 1997) but is 56
most structurally similar to the longer neuronal form of pro- 57
interleukin16 (npro-IL-16, Kurschner and Yuzaki, 1999), which is 58
a 5-PDZ domain protein. Npro-IL-16 has been reported to interact 59
with theNMDAreceptor subunit 2AandKv4channels in interaction 60
assays (Kurschner and Yuzaki, 1999). The interactions of npro-IL- 61
16 with Kv4.2 in the hippocampus and cerebellum were recently 62
found to modulate Kv4.2 channel function (Fenster et al., 2007). 63
The structural similarity between npro-IL-16 and Pdzd2 implies a 64
potential intracellular role for Pdzd2, acting as a scaffolding protein 65
for targeting receptors or ion channels. The purpose of this study 66
was to establish mouse lines in which Pdzd2 is disrupted by gene- 67
trapmutagenesis in order to address the functional role of this large 68
PDZ protein in the endocrine pancreas or -cell physiology in vivo. 69
0303-7207/$ – see front matter © 2009 Published by Elsevier Ireland Ltd.
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In addition, silencing of Pdzd2 expression in the-cell-derived INS-70
1E linewasperformedusing siRNAs to confirmfunctional relevance71
in vitro. Our results show that without affecting the expression72
of the KATP channel subunits, basal insulin secretion is distorted73
in Pdzd2-deficient mice as well as in the Pdzd2-depleted INS-1E74
cells and suggest that Pdzd2 is required in the regulation of insulin75
exocytosis through modulation of KATP channel activity.76
2. Materials and methods77
2.1. Generation of the gene-trap (Pdzd2Gt/Gt) mutant mice78
Two mouse ES lines, S3-7A and S7-9G, with the Pdzd2 locus mutated by gene-79
trap mutagenesis, were purchased from Fred Hutchinson Cancer Research Center.80
These ES cells were used to generate chimeras by blastocyte (C57/Bl6) injection and81
germline transmission of the mutant allele was achieved by crossing the chimeras82
to 129/SvEv mice. Homozygous mutants (designated Pdzd2Gt/Gt-A and Pdzd2Gt/Gt-B)83
were generated by intercrossing heterozygotes. To suppress transcription down-84
stream of the sites of insertion of the retroviral gene-trap vector ROSAFARY (Chen et85
al., 2004), the PGK promoter flanked with FRT sites within ROSAFARY was removed86
by crossing with a mouse line that constitutively expressed the Flp recombinase.87
Mutant and wild-type mice were bred and housed in the Minimal Disease Area88
(MDA) unit at the University of Hong Kong. Sex- and age-matched mutants and89
their non-transgenic littermates were used in the present study. All animal proce-90
dures have been approved by the Committee on the Use of Live Animals in Teaching91
& Research at the University of Hong Kong.92
2.2. Evaluation of glucose tolerance and plasma insulin93
Mice were starved for 14h prior to the glucose challenge. Two grams of glu-94
cose per kg of body weight, in a 20% (w/v) glucose solution, was injected into the95
peritoneal cavity of individual animals. Blood glucose levels of themice weremoni-96
tored 30min before and 10, 20, 30, 60 and 120min after glucose injection using the97
Glucometer Elite (Bayor Inc.). As insulin levels were measured, blood samples were98
drawn from the animals 30min prior to and 2.5, 5, 10, 15, 30 and 60min after glu-99
cose injection using the Microvette CB300 lithium heparin-coated blood collection100
device (Sarstedt, Germany).Whole blood sampleswere subsequently centrifuged at101
4600 rpm for 5min at room temperature. Plasmawas collected and stored at −20 ◦C102
until use. Plasma insulin levels were measured utilizing an insulin ELISA kit (LINCO103
Research, USA). For insulin tolerance tests, mice starved for 7h were injected with104
insulin at 0.75 IU/kg and the blood glucose levels measured at the indicated time105
intervals.106
2.3. Islet isolation and culture107
Miceweresacrificedbycervicaldislocation. Thepancreatic tissuewasharvested,108
rinsed and trimmed of fat, as previously described (Lau et al., 2004). Briefly, two109
pancreases were placed in 8mL HBSS containing 25mg collagenase A (Roche) at110
37 ◦C for 25min with vigorous shaking. The islets were handpicked under a light111
microscope and were cultured in RPMI 1640 medium. Typically, islets became free112
of other contaminating cell types after 3 days of incubation and were ready for113
different assays.114
2.4. INS-1E cell culture and RNAi115
Twopairs of the siRNAduplexes, designated as duplex2 (sense: 5′-UUCUCCGAA116
CGU GUC ACG UdTdT-3′ and antisense: 5′-ACG UGA CAC GUU CGG AGA AdTdT-3′117
from Qiagen) and duplex3 (sense: 5′-GCU GCA GGA GUA CAU CCA AdTdT-3′ and118
antisense:5′-UUGGAUGUACUCCUGCAGCdTdT-3′ fromHealth&Co.),were specifi-119
cally designed for targeting the third andfirst PDZdomain, respectively, of rat Pdzd2,120
whereasonenon-silencingsiRNAduplex,duplex1 (sense:5′-UUCUCCGAACGUGUC121
ACG UdTdT-3′ and antisense: 5′-ACG UGA CAC GUU CGG AGA AdTdT-3′ from Qia-122
gen),wasusedas anegative control. siRNAoligos (10nM)weredelivered into INS-1E123
cells using HiPerfect transfection reagent (Qiagen) according to the manufacturer’s124
instructions. Samples were harvested 48h after transfection.125
2.5. RT-PCR analysis126
Total RNA from islets or INS-1E cells was isolated in TRIzol (GIBCO) accord-127
ing to the manufacturer’s instructions. Two micrograms of total RNA were reverse128
transcribed using randomhexamers and SuperScript II Reverse Transcriptase (Invit-129
rogen). Various mouse and rat cDNAs were amplified by PCR using SuperMix II130
(Invitrogen) and the conditions were as follows: an initial denaturation at 94 ◦C131
for 1min; repeated cycles of denaturation at 94 ◦C for 15 s, annealing at 55–58 ◦C132
for 30–45 s and extension at 68 ◦C for 2min; and a final PCR cycle with an addi-133
tional extension step at 68 ◦C for 8min. All amplifications were performed for134
20–40 cycles and the number of cycles was optimized to fall within the linear135
range for semi-quantitative analysis. For TaqMan-based real-time PCR analysis of136
Glut2 (Mm00446224 m1) and Insulin (Mm01950294 s1) transcripts, reactionswere137
performed using the ABI 7500 Real-Time PCR system with the following thermal 138
cycle program: 5min at 95 ◦C followed by 40 cycles of 15 s at 95 ◦C and 35 s at 139
60 ◦C. Reactions were performed in triplicate with gene expression normalized to 140
glyceraldehyde-3-phosphate dehydrogenase and data analyzed using comparative 141
Ct method. Details about primer design will be furnished upon request. 142
2.6. Immunohistochemical, histomorphometric and western blot analyses 143
Pancreatic tissues were fixed in 4% paraformaldehyde in PBS and cleared with 144
xylene. Paraffin-embedded tissue blocks were sectioned into 6m slices using 145
the microtome machine. Slides were de-paraffinized, briefly rinsed with PBS and 146
exposed to primary antibodies, anti-Pdzd2 [1:1000 for C-terminus antibody (Yeung 147
et al., 2003); 1:2500 for N-terminus antibody], anti-insulin (pre-diluted, LINCO 148
Research) and anti-glucagon (1:2000, DakoCytomation) for about 16h at 4 ◦C. After 149
severalwasheswith Tris-buffered saline containing 0.1% Tween-20 (TBS-T), the sec- 150
tions were incubated with HRP-, Cy3- or Cy5-conjugated anti-rabbit or anti-goat 151
secondary antibodies at room temperature for 1h. For DAB staining, sections were 152
covered with liquid DAB and substrate-chromogen solution from the EnVision+ 153
System-HRP (DAB) kit (DakoCytomation). The anti-Pdzd2 N-terminus antibodywas 154
raised against the peptide sequence CDTADDPSSELENGT (amino acids 240–254) 155
identified within mouse Pdzd2 and was partially purified by the manufacturer 156
(United States Biological). Islet area and islet mass were determined according to 157
Skau et al. (2001). 158
Protein from INS-1E cells or islets was extracted in RIPA buffer [150mM NaCl, 159
1% NP-40, 0.5% deoxycholate, 1mM EDTA, 50mM Tris–HCl (pH 7.4), proteinase 160
inhibitor cocktail (Roche Applied Science)] on ice. Samples were then solubilized in 161
5× SDS sample buffer [62.5mM Tris–HCl (pH 6.8), 2% SDS, 5% -mercaptoethanol, 162
0.025% bromophenol blue, 20% glycerol]. Twenty micrograms of protein were 163
resolved on SDS polyacrylamide gels (7.5–15%), subjected to electrophoresis and 164
transferred to Hybond-C membranes (Amersham). Bound proteins were blocked 165
with 5% non-fat dry milk in TBS-T at room temperature for 1h, and were probed 166
with specific primary antibodies against Pdzd2 (1:1000, 13), SUR1 (1:250,H-80 from 167
Santa Cruz), Kir6.2 (1:250, N-18 from Santa Cruz) and-Tubulin (1:1000, NeoMark- 168
ers) overnight at 4 ◦C. Membranes were then washed with TBS-T and incubated 169
with appropriate HRP-conjugated secondary antibodies at room temperature for 170
half an hour. Immunoreactive bands were visualized using an enhanced chemilu- 171
minescence detection system (Pierce). 172
2.7. Assays for insulin secretion 173
In a 24-well plate, INS-1E cells were seeded at a density of 4×104 or groups 174
of 15 isolated mouse islets were placed (Lau et al., 2004). After pre-incubation in 175
complete RPMI 1640medium containing 2.8mM glucose for 4h, cells or islets were 176
briefly washed with PBS. At time 0, samples were incubated in 0.5mL Krebs–Ringer 177
bicarbonate (KRB) buffer supplemented with 2.8mM glucose for 30min at 37 ◦C. 178
The ambient buffer was then collected for the measurement of insulin secretion. 179
At time 30min, samples were switched to be incubated in 0.5mL KRB buffer con- 180
taining 16.7mM glucose for another 30min at 37 ◦C. Again, the ambient buffer was 181
collected for determination of insulin secretion after glucose stimulation. Besides 182
glucose, INS-1E cells and mouse islets were subjected to various stimuli, including 183
100M tolbutamide (Sigma), 300M diazoxide (Sigma) and 30mM KCl. Insulin 184
concentrations in the collected samples were measured using an insulin ELISA kit 185
(LINCO Research) and were normalized to the corresponding insulin content. 186
2.8. Statistical analyses 187
Thedataarepresentedasmeans± S.E.M. Significancewasevaluatedbyunpaired 188
Student’s t-test or one-way analysis of variance (ANOVA) with appropriate post 189
hoc tests. Statistical significance by either unpaired Student’s t-test or ANOVA is 190
explicitly identified by text or in the figure legends. 191
3. Results 192
3.1. Pdzd2 expression is disrupted in two mouse gene-trap lines 193
Both Pdzd2 heterozygous and homozygous mutants derived 194
from the two gene-trap lines were viable and appeared grossly 195
morphologically normal. To avoid extensive hormonal effects in 196
physiological assays, male animals were used in experiments and 197
only wild-type and homozygous mutant mice were studied to 198
clearly detect any loss-of-function phenotype. The viral insertion 199
sites of both Pdzd2Gt/Gt-A and Pdzd2Gt/Gt-B lines are downstream of 200
the first coding exon (Exon 1) of Pdzd2 and they are about 35,000bp 201
apart (Fig. 1A). RT-PCR analysis of Pdzd2 transcripts revealed that 202
splicing from Exon 1 to Exon 2 was disrupted in the gene-trap 203
mutants of both lines (Fig. 1B, Primers 1 and 2). As a result, 204
transcription across Exon 2 and Exon 3 was also halted (Fig. 1B, 205
Primers 3 and 4). Next, we examined the protein levels of Pdzd2 206
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Fig. 1. Characterization of the gene-trap (Pdzd2Gt/Gt) mutant mice. (A) Schematic representation of the structure of the Pdzd2 protein and Pdzd2 locus. The viral insertion
sites in the gene-trap (Pdzd2Gt/Gt-A and Pdzd2Gt/Gt-B) mutant mice are indicated by downward pointing arrows. (B) RT-PCR analysis of splicing from Exon 1 to Exon 2 and
from Exon 2 to Exon 3 in the mutant and wild-type mice. (C) Immunoblot analysis of Pdzd2 expression in pancreatic homogenates using the anti-Pdzd2 C-antibody. (D)
Immunostaining of pancreatic sections using the anti-Pdzd2 N-antibody. Pdzd2 expression was visualized by DAB and counterstained with hematoxylin. Arrows indicate
the position of islets. Magnification 200×.
in pancreatic tissues by immunoblot analysis utilizing an anti-207
Pdzd2 C-terminus antibody. The expression of Pdzd2 (∼300kDa)208
in the gene-trap mutant pancreases was suppressed when com-209
pared with those from the wild-type mice (Fig. 1C). The disruption210
in expression of this large Pdzd2 protein was further confirmed211
by immunostaining using an anti-Pdzd2 N-terminus antibody212
(Fig. 1D). This analysis confirmed the islet-enriched expression of213
Pdzd2 that was lost in the gene-trap mutant pancreases.214
3.2. Pdzd2 deficiency has no detectable effect on islet morphology 215
or expression of important ˇ-cell markers 216
Immunohistochemical studies were performed using antibod- 217
ies against the major pancreatic endocrine hormones, insulin 218
and glucagon, to identify  and  cells. Pancreatic sections from 219
wild-type and Pdzd2Gt/Gt-A mutants were found to contain the 220
two islet cell types and no notable alteration was observed in 221
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Fig. 2. Analysis of islet morphology and gene expression in gene-trap (Pdzd2Gt/Gt) mutant mice. (A) Immunohistochemical analysis of pancreatic sections isolated from
3-month-old wild-type and Pdzd2Gt/Gt-A mutant mice. Sections were stained with DAPI (DNA dye) and antibodies against insulin and glucagon. Magnification 200×. (B) Islet
area and islet mass were determined by morphometric analysis of pancreatic sections. (C) Real-time PCR analysis of Glut2 and Insulin transcripts in wild-type and mutant
pancreases. Data are means± S.E. of values from at least three mice of each genotype.
their localization (Fig. 2A). In addition, histomorphometric analysis222
of insulin-expressing cells did not reveal any significant differ-223
ence in islet mass or islet area/pancreas in Pdzd2Gt/Gt-A mutants224
(Fig. 2B) and themRNAexpressionof two important-cellmarkers,225
Insulin and Glut2, was not significantly affected by Pdzd2 defi-226
ciency (Fig. 2C). Similar resultswerealsoobtained fromPdzd2Gt/Gt-B227
mutants (datanot shown).Hence, Pdzd2deficiencydoesnot appear228
to have any negative effect on the formation of the different islet229
cell types, general islet morphology and -cell mass.230
3.3. Pdzd2Gt/Gt mutant mice have slightly lower body weight and231
show enhanced glucose tolerance232
At the ages of 2 and 3 months, the body weight of Pdzd2Gt/Gt233
mutants, from both lines A and B, was found to be lower when234
compared with the wild-type mice (Fig. 3A). Moreover, Pdzd2Gt/Gt235
mutants exhibited a relative lower level of blood glucose in the 236
random-fed state (Fig. 3B), alongwith a slightly higher plasma level 237
of insulin (Fig. 3C). However, those differences were not regarded 238
as statistically significant. To investigate possible change in glucose 239
homeostasis in the Pdzd2Gt/Gt mice, an intraperitoneal injection of 240
glucose at 2 g/kg of body weight was given to animals (at 1, 2 and 241
3 months of age) that had been fasted overnight. Interestingly, 242
Pdzd2Gt/Gt mutants of both lines A and B at 2 and 3 months of age 243
showed a faster clearance of blood glucose in contrast to wild-type 244
mice; the differences were most significant at 20 and 30min after 245
glucose injection (Fig. 4B andC). However, such a phenomenonwas 246
not observedwhen the animals were only 1-month old, suggesting 247
a delayed onset of phenotype (Fig. 4A). The faster glucose clearance 248
could not be attributed to increased insulin sensitivity of peripheral 249
tissues as insulin tolerance tests revealed comparable responses in 250
wild-type and Pdzd2Gt/Gt-A mutants (Supplementary Fig. 1). 251
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Fig. 3. Pdzd2Gt/Gt mutant mice have lower body weight. The body weight (A), fed-
state blood glucose level (B) and fed-state plasma insulin level (C) were monitored
when mice were 1, 2 and 3 months old. Data are means± S.E. of values from 10 (A),
7 (B) or 4 (C) mice of each genotype. *p<0.05.
3.4. Pdzd2Gt/Gt mice have increased basal level of insulin secretion252
To assess the physiological basis of the lowering of blood glu-253
cose levels in Pdzd2Gt/Gt-Amice (at 3months of age), plasma insulin254
levels were measured at different time points after glucose stimu-255
lation. The plasma insulin concentrations in Pdzd2Gt/Gt-A mutants256
at all the time points from T=0 to T=15 (T=0 represented the basal257
level), were notably higher than those in wild-type mice (Fig. 5A).258
There was an increase in basal level of insulin secretion such that259
the transient peak of plasma insulin detected after 2.5min was260
significantly elevated in the mutants compared to wild-type. The261
initial peak abated for both wild-type and mutant mice, with a262
Fig. 4. Effect of Pdzd2 depletion on glucose clearance. Intraperitoneal glucose toler-
ance testswere performed inwild-type and Pdzd2Gt/Gt mice at 1month (A), 2months
(B) and 3months (C) of age after fasting for 14h. Data aremeans± S.E. of values from
8 (A) or 6 (B and C) mice of each genotype. *p<0.05.
continued higher level for the mutant mice at 10 and 15min. The 263
wild-type mice then showed a second peak at 30min which was 264
absent in the mutant mice. Nevertheless, we cannot rule out the 265
possibility of an early or delayed second peak without measure- 266
ment of insulin secretion at more time points (between T=15 and 267
T=60). These findings indicated that Pdzd2Gt/Gt mutants exhibited 268
a significantly stronger basal level of insulin release. 269
3.5. Insulin secretion is abnormal in isolated mutant islets 270
To further investigate the effect of Pdzd2 deficiency on insulin 271
secretion, glucose- or KCl-stimulated insulin releasewith islets iso- 272
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Fig. 5. Abnormal insulin secretion from Pdzd2Gt/Gt mutant mice and isolated islets. (A) Glucose-stimulated insulin secretion was performed in wild-type and Pdzd2Gt/Gt-A
mutant mice that had fasted for 14h. (B and C) Insulin release responses were measured from wild-type and Pdzd2Gt/Gt-A mutant islets under the indicated concentrations
of glucose (B) and KCl (C). (D and E) Insulin secretion was measured from both wild-type and Pdzd2Gt/Gt-A mutant islets after treatment with the KATP channel inhibitor
tolbutamine (D) or the KATP channel activator diazoxide (E) in the presence of 8.4mM glucose. Values are means± S.E. of values from 4 or 5 individual experiments. *p<0.01;
**p<0.001.
lated from Pdzd2Gt/Gt-Amutant andwild-typemicewasmonitored.273
For such experiments, isolated islets were subdivided into groups274
of 15with size-matching. At lowconcentrationof glucose (2.8mM),275
insulin release from Pdzd2Gt/Gt isletswas about twofold higher than276
from normal islets (Fig. 5B). At 16.7mM glucose, insulin secre-277
tion from both Pdzd2Gt/Gt and wild-type islets was essentially the278
same. KCl at 30mM is known to elicit insulin release by inducing279
membrane depolarization. The secretory response of the mutant280
islets to 4.8mM KCl was higher than that of the normal islets,281
despite their similar level of response to 30mMKCl (Fig. 5C). These282
results indicated that Pdzd2 is required for normal insulin secretion283
and disruption of Pdzd2 expression perturbed the control of basal284
insulin release consistent with the plasma insulin analysis.285
The KATP channel is known to be the key regulator of insulin286
secretion by maintaining hyperpolarization of  cells and it is the287
closure of the KATP channel by increased ATP levels after glucose288
intake that triggers depolarization and eventually insulin secretion.289
RT-PCR and western analyses showed that the expression levels290
of the KATP channel subunits were not suppressed by Pdzd2 defi-291
ciency (data not shown). To investigate the functional involvement292
of the KATP channel in mediating the Pdzd2-dependent defect, the293
effects of tolbutamine (100M) and diazoxide (300M)which are294
inhibitor and activator, respectively, of KATP channel activity were 295
tested. We argue that if the Pdzd2 effect were mediated via reg- 296
ulation of KATP channel activity, the Pdzd2-dependent defect on 297
insulin secretion would be lost if KATP channel activity was sup- 298
pressed by tolbutamine treatment. Indeed, when tolbutamine was 299
applied, insulin release from both wild-type and mutant islets was 300
increased to comparable levels (Fig. 5D). In contrast, when the KATP 301
channel activator diazoxide was present, insulin release from both 302
wild-type andmutant isletswasdecreasedbut the insulin secretion 303
frommutant islets was still maintained higher (Fig. 5E), suggesting 304
that the Pdzd2-dependent effect is mediated through regulation of 305
KATP channel activity. 306
3.6. Silencing of Pdzd2 expression in INS-1E cells produces similar 307
phenotypic effect as the mutant islets 308
To study the function of Pdzd2 in vitro, we designed two siRNA 309
duplexes (duplexes 2 and 3) for silencing Pdzd2 expression by 310
transient transfection into the -cell-derived INS-1E cell line. A 311
non-silencing duplex (duplex 1) was also analyzed in parallel. RT- 312
PCR and immunoblot analyses revealed that Pdzd2 at both RNA and 313
protein levels was depleted by both silencing duplexes 48h after 314
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Fig. 6. Knockdown of Pdzd2 expression in INS-1E cells. (A and B) Silencing effects of
different siRNA duplexes on Pdzd2 expression were examined by means of RT-PCR
(A) and western analyses (B). Duplex1 is the non-silencing control. (C) Glucose-
stimulated insulin secretion. In the siRNA-transfected INS-1E cells, insulin release
in response to indicated concentrations of glucosewasmeasured bymeans of ELISA.
Data are means± S.E. of values from 4 separate experiments. *p<0.05.
transfection (Fig. 6A and B). To further explore the effect of Pdzd2315
silencing on insulin secretion, transfected cells were subjected to316
GSIS assays. Insulin secretionwasmeasured using ELISA after incu-317
bation for 1h in both basal (2.8mM) and stimulatory (16.7mM)318
doses of glucose. Similar to the ex vivo results, INS-1E cells under319
knockdown conditions secreted nearly 20% more insulin even at320
the non-stimulatory concentration of glucose (2.8mM). In contrast,321
their responses to 16.7mM glucose were comparable to the con-322
trol cells (Fig. 6C). When transfected INS-1E cells were similarly323
treated with tolbutamine and diazoxide to study the involvement324
of the KATP channel, the effect of Pdzd2 knockdown was abolished325
when KATP channel activity was inhibited (Supplementary Fig. 2B)326
but not when the channel was activated (Supplementary Fig. 2C).327
Taken together, these results suggested that insulin secretion328
was distorted by Pdzd2 deficiency. At low concentrations of glu-329
cose, basal insulin secretion of both Pdzd2-deficient islets and330
INS-1E cells was abnormally increased. The difference in response331
of wild-type and mutant islets to tolbutamine and diazoxide, and332
similarly for normal and Pdzd2-depleted INS-1E cells, suggested333
that the enhanced insulin exocytosis was primarily mediated by334
suppression of KATP channel activity.335
4. Discussion336
In this study, we utilized gene-trap mutagenesis to uncover a337
functional role of Pdzd2 in insulin secretion and glucose home-338
ostasis. Thephysiological defectwas very evident in intraperitoneal339
glucose tolerance tests when Pdzd2Gt/Gt mutant mice exhibited an340
unusually faster clearanceof glucose.Pdzd2Gt/Gt mutantmicedevel-341
oped with an elevated basal level of plasma insulin in the fasting342
state. The functional defect could be observed in two independent343
mouse lines with the mutagenic retrovirus inserted 35kb apart344
within thefirst intronof thePdzd2 locus, ruling out thepossibility of 345
a secondary effect. Since enhanced basal level of insulin releasewas 346
reproduced in Pdzd2Gt/Gt mutant islets in ex vivo assays and insulin 347
tolerance tests argued against a significant change in insulin sen- 348
sitivity in peripheral tissues, the physiological response of insulin 349
secretion in mutant mice was attributable to the pancreatic islets. 350
Without any obvious change in composition of various pancreatic 351
endocrine cell types, the increased secretion of insulin could not be 352
explained by changes in cell mass of individual cell types. 353
In normal pancreatic  cells, basal release of insulin is tightly 354
suppressed when the ambient glucose concentration is low. The 355
release of insulin granules is known to be controlled by sev- 356
eral mechanisms, and the KATP channel is one of the most 357
important governing gates (Straub and Sharp, 2002). The KATP 358
channel exists as an octameric complex of 2 subunits, SUR1 and 359
Kir6.2, and its activity is thereby regulated by these two proteins 360
(Ashcroft and Gribble, 1999). Mice lacking Kir6.2 developed tran- 361
sient hypoglycemia as insulin secretion was not suppressed at low 362
concentrations of glucose (Seino et al., 2000), and suppression of 363
beta cell KATP channel activity was found to induce hyperinsulin- 364
ism (Koster et al., 2002). In the current study, Pdzd2Gt/Gt mutant 365
mice showed an elevated level of plasma insulin during fasting and 366
insulin secretion in Pdzd2Gt/Gt mutant islets was not sufficiently 367
suppressed at 2.8mM glucose, consistent with a perturbation of 368
KATP channel activity. By means of RNAi to deplete Pdzd2 expres- 369
sion in INS-1E cells, abnormal insulin responses were observed. 370
The KATP channel being a target of Pdzd2 action is also supported 371
by the differential response of mutant islets and Pdzd2-depleted 372
INS-1E cells to tolbutamine and diazoxide. It is interesting to note 373
that comparable levels of insulin secretion at 16.7mMglucosewere 374
observed in islets isolated from both wild-type and mutant islets. 375
These findings are supportive of an early insulin release in the 376
mutant mice that led to faster glucose clearance while the total 377
amount of secreted insulin remained unaffected. Based on these 378
in vivo and in vitro studies, it is plausible that Pdzd2 takes part in 379
the regulation of insulin secretion via modulation of KATP channel 380
activity. Without any apparent decrease in the expression of the 381
KATP channel subunits, we believe that it was the functional activ- 382
ity rather than the expression level of the KATP channel that was 383
affected in the mutant islets. 384
As a multi-PDZ domain protein, it is conceivable that Pdzd2 385
may modulate channel activity by serving as a molecular scaffold 386
to mediate the formation of multi-molecular complexes (Nourry 387
et al., 2003; Kim and Sheng, 2004; Harris and Lim, 2001). One of 388
the highly comparable PDZ domain proteins, npro-IL-16, has been 389
reported to interact physically with the NMDA receptor subunit 390
2A and Kv4 channels (Kurschner and Yuzaki, 1999). A recent study 391
has shown that npro-IL-16 modulates A-type potassium channel 392
function via regulating channel trafficking in the hippocampus and 393
cerebellum (Fenster et al., 2007). Npro-IL-16 regulates the surface 394
expression of Kv4.2 by altering its intracellular clustering, with- 395
out any effect on Kv4.2 protein expression levels. Since Pdzd2 396
is required for suppressing insulin exocytosis, it may function to 397
enhance the intracellular trafficking and hence surface expression 398
of the KATP channel in pancreatic  cells. Further interaction assays 399
need to be performed to test whether Pdzd2 interacts directly 400
with the KATP channel subunit SUR1 and Kir6.2. It remains to be 401
tested whether Pdzd2 would also interact with signaling lipids 402
(Zimmermann, 2006) tomediate its regulatory function. It is worth 403
noting that Pdzd2 has recently been predicted to interact with a 404
variety of ion channels in a large-scale analysis of PDZ interac- 405
tions (Stiffler et al., 2007). Consistent with this prediction, Shao et 406
al. (2009) recently detected a direct interaction of Pdzd2 with the 407
voltage-gated sodium channel Nav1.8 and siRNA-depleted Pdzd2 408
expression in sensory neurons led to inhibition of endogenous 409
Nav1.8 current. Interestingly, no significant change in pain behav- 410
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iors could be detected when the Pdzd2-deficient mice reported411
in this study were analyzed for pain sensation, probably due to412
the compensatory upregulation of another Nav1.8 regulatory fac-413
tor p11 (Shao et al., 2009). Mouse models for conditional knockout414
of Pdzd2 would need to be established to further study the tissue-415
or cell type-specific function of Pdzd2.416
Hitherto, studies of Pdzd2 function have mostly been focused417
on the secreted form generated by caspase-dependent proteolytic418
processing of the full-length form (Yeung et al., 2003; Thomas et al.,419
2009). In a concentration-dependent fashion, recombinant sPDZD2420
has been shown to stimulate the proliferation anddifferentiation of421
INS-1E cells in vitro (Ma et al., 2006; Suen et al., 2008; Leung et al.,422
2009). Although it is surprising to note a lack of perturbation of -423
cell mass and gene expression in the Pdzd2mutantmice, our study424
revealed a role for Pdzd2 in the regulation of basal insulin secre-425
tion. In summary, Pdzd2 depletion leads to increased basal release426
of insulin. The tight suppression of insulin release is lost suggest-427
ing that Pdzd2 is required for activation of the KATP channel. The428
identification of putative interactors of Pdzd2 may provide further429
insight into the molecular basis of Pdzd2 function. Since dysfunc-430
tion of the KATP channel and insulin secretion has been implicated431
in the development of diabetes, it would also be interesting to432
know whether the defective insulin secretion in Pdzd2-deficient433
mice leads to diabetes or impaired glucose tolerance with aging or434
diet-induced obesity.435
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